Very good and extensive piece on five things investors should forward to at the big ASCO event that… - Biotech Maven

Very good and extensive piece on five things investors should forward to at the big ASCO event that kicks off this weekend

.

Brad Loncar's ASCO19 preview: 5 big ideas to watch for at the ultimate cancer show of the year

Brad Loncar's ASCO19 preview: 5 big ideas to watch for at the ultimate cancer show of the year

Friday marks the beginning of yet another ASCO Annual Meeting. For those of us who follow cancer research closely, this will always be…

Comments

Despite late-stage win, investors not sold on Global Blood sickle cell drug

Despite late-stage win, investors not sold on Global Blood sickle cell drug

www.biopharmadive.com

Good piece on why Global Blood Therapeutics might be down today despite solid results on primary…

EditorBret Jensen

2 days

Like

Like

As another antibiotics biotech sinks into a crisis, warnings of a sector ‘collapse’

As another antibiotics biotech sinks into a crisis, warnings of a sector ‘collapse’

Good piece on the ridiculous hard economics of the antibiotic space even with newly approved drugs

EditorBret Jensen

3 days

Like

Like

Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout

Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout

Good piece on the current regulatory delays and possible impacts around Spark Therapeutics…

EditorBret Jensen

6 days

Like

Like